Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06724198

Bowel Dysfunction After Low Rectal Resection. An Pilot Study Using Psyllium Husk In Rectal Cancer Patients.

Quality of Life (QoL) and Symptom Burden After Low Rectal Resection. An Open, Effect Pilot Study With Psyllium Husk Treatment in Rectal Cancer Patients.

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Sykehuset Telemark · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Rectal cancer constitutes 1/3 of more than 4500 annually diagnosed cases of colorectal (CRC) in Norway. With the advances in radiochemotherapy, and surgical techniques, the long-term survival rate is increasing after surgery regardless of the rising incidences, with a 73% 5-year survival rate in Norway (89% for stage I-III cancer). Low anterior resection (LAR) is the most commonly performed surgical procedure with curative intent with over 500 procedures per year in Norway alone. 80 % of patients subjected to LAR suffer from the LAR syndrome (LARS) which includes grades of bowel incontinence, urgency and tenesmus contributing to reduced quality of life (QoL). Suggested means of management have been advocated without preceding randomized trials. Psyllium husk has been suggested as a nutritional supplement for symptom reduction in patients suffering from LARS, but data is limited and no larger, randomized studies regarding its effect on patients with low anterior resection syndrome have been conducted. In this pilot study preceeding a placebo-controlled RCT, the investigators aim to improve documentation of a proposed management strategy. The investigators anticipate that a reduction in intestinal symptomburden will increase QoL for this large patientgroup.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPsyllium husk3.66 gram Psyllium husk twice daily for 8 weeks

Timeline

Start date
2025-01-01
Primary completion
2025-07-01
Completion
2025-09-01
First posted
2024-12-09
Last updated
2025-07-09

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT06724198. Inclusion in this directory is not an endorsement.